Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL15473580 | 0.88 | ALDH1A1 (0.32) | ALDH1A1L3MBTL1 | |
| Oxalic Acid SCHEMBL5013712 | 0.82 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1 | |
| Tetrylammonium SCHEMBL5013722 | 0.79 | TSHR (0.32) | — | |
| Tetrylammonium SCHEMBL5015082 | 0.79 | TSHR (0.32) | — | |
| Oxalic Acid SCHEMBL5013740 | 0.78 | — | — | |
| Tetrylammonium SCHEMBL5013736 | 0.76 | — | — | |
| Oxalic Acid SCHEMBL27725525 | 0.76 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1 | |
| Tetrylammonium SCHEMBL159931 | 0.74 | TSHR (0.42) | ALDH1A1L3MBTL1 | |
| Tetrylammonium SCHEMBL5022910 | 0.74 | MAPT (0.31) | — | |
| Tetrylammonium SCHEMBL5015057 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8652682-B2 | Ionic compound, electrolytic solution, electrochemical device, and battery | SONY CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | SONY CORPORATION (JP) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | CA2, DUOX2, OTC | ALDH1A1 2771/4885L3MBTL1 1478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.